Cohort analysis of hip dysplasia treatment using arthroscopy
Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia
Peking University Third Hospital · NCT06512506
This study looks at how well different arthroscopic treatments work for people with borderline hip dysplasia to help improve their recovery and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 47 (estimated) |
| Sex | All |
| Sponsor | Peking University Third Hospital (other) |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06512506 on ClinicalTrials.gov |
What this trial studies
This study conducts a cohort analysis of patients with borderline developmental dysplasia of the hip (BDDH) who have undergone arthroscopic treatment for glenolabial injuries. It aims to optimize the indications for minimally invasive surgery and improve surgical outcomes by analyzing the efficacy of different surgical techniques. The research builds on previous findings to enhance patient selection and surgical measures, ultimately promoting better rehabilitation and functional recovery for patients. The study is observational and does not involve any experimental interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with borderline hip dysplasia accompanied by glenolabial injury.
Not a fit: Patients with conditions unrelated to borderline hip dysplasia or those not experiencing glenolabial injuries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and faster recovery for patients with hip dysplasia.
How similar studies have performed: While this study builds on previous research, the specific approach of optimizing minimally invasive surgery for BDDH is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Diagnosis of borderline hip dysplasia with glenolabial injury. Exclusion Criteria: \-
Where this trial is running
Beijing
- Peking University Third Hospital Medicial Science Research Ethics Committee — Beijing, China (RECRUITING)
Study contacts
- Study coordinator: Jianquan Wang, M.D.
- Email: wjqsportsmed@163.com
- Phone: 13253137009
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Developmental Dysplasia of the Hip